DIANE COZZO: Open Payments
NPI 1215019930 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 39 payments from 8 companies in 2025. Trend: 2023 $367 · 2024 $926 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $158 |
| PFIZER INC. | 12 | $146 |
| Phathom Pharmaceuticals, Inc. | 4 | $122 |
| Amgen Inc. | 7 | $120 |
| Lilly USA, LLC | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VOQUEZNA, MOUNJARO, OTEZLA, ELIQUIS, Ozempic, PREVNAR 20, FARXIGA, REPATHA.
Industry payments across NY — which companies pay providers there.
